Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Translational Oncology|December 19, 2020
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activityAhmed I Younes, Hampartsoum B Barsoumian, Duygu Sezen, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 23, 2020
Impact of Prolonged Neoadjuvant Treatment-surgery Interval on Histopathologic and Operative Outcomes in Patients Undergoing Total Mesorectal Excision for Locally Advanced Rectal CancerAta C Akbaba, Serkan Zenger, Erman Aytac, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 5, 2024
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapyYun Hu, Alexey Revenko, Hampartsoum Barsoumian, et al.
Journal of Nanobiotechnology|September 19, 2022
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancerYun Hu, Sébastien Paris, Genevieve Bertolet, et al.
Cancer Immunology Research|January 26, 2023
Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung CancerKewen He, Hampartsoum B Barsoumian, Nahum Puebla-Osorio, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Significant Correlation of Dynamic Pan-Immune Inflammation Value and Magnetic Resonance Imaging Response in Patients with Locally Advanced Rectal Cancer Treated with Total Neoadjuvant TherapySukran Celikarslan, Duygu Karahacioglu, Bengi Gurses, et al.
Frontiers in Oncology|October 24, 2024
Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapyNahum Puebla-Osorio, Natalie Wall Fowlkes, Hampartsoum B Barsoumian, et al.
Cancers|July 15, 2026
Induction Chemoimmunotherapy Followed by Consolidative Hypofractionated Radiotherapy for Unresectable Locally Advanced NSCLC: A Real-World Outcomes AnalysisCaglayan Selenge Beduk Esen, Sukran Celikarslan, Duygu Sezen, et al.
Clinical Lung Cancer|April 26, 2026
Real-World Clinical Outcomes of Concurrent Chemotherapy and Dose-Escalated Twice-Daily Radiotherapy With Simultaneous Integrated Boost (SIB) for Limited-Stage Small Cell Lung CancerSukran Celikarslan, Duygu Sezen, Merve Duman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2021
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trialRoshal R Patel, Kewen He, Hampartsoum B Barsoumian, et al.
Pageof 4